# Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

> **NCT01199887** · PHASE1 · COMPLETED · sponsor: **ImmuneWorks** · enrollment: 30 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** IW001

## Key facts

- **NCT ID:** NCT01199887
- **Lead sponsor:** ImmuneWorks
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01199887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01199887, "Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01199887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*